- Open
- 2.85
- High
- 2.91
- Low
- 2.70
- Close
- 2.79
- Change
- -0.25 (-8.77%)
- Volume
- 810,022
| 7 Jul 2026 | 16:36:12 | Holding(s) in Company |
| 30 Jun 2026 | 07:00:07 | Real world evidence study data published |
| 29 May 2026 | 16:24:27 | Holding(s) in Company |
| 27 May 2026 | 11:20:36 | Holding(s) in Company |
| 18 May 2026 | 15:52:13 | Holding(s) in Company |
| 7 Jan 2025 | Annual Report and Accounts (to 2024-06-30) | |
| 16 Jan 2024 | Annual Report and Accounts (to 2023-06-30) | |
| 30 Dec 2022 | Annual Report and Accounts (to 2022-06-30) |
Renalytix is a company that uses artificial intelligence to develop diagnostic tools for kidney disease. Their goal is to improve patient outcomes and reduce healthcare costs by optimizing clinical management of this condition.
| 7 Jul 2026 | 16:36:12 | Holding(s) in Company |
| 30 Jun 2026 | 07:00:07 | Real world evidence study data published |
| 29 May 2026 | 16:24:27 | Holding(s) in Company |
| 27 May 2026 | 11:20:36 | Holding(s) in Company |
| 18 May 2026 | 15:52:13 | Holding(s) in Company |
| 7 Jan 2025 | Annual Report and Accounts (to 2024-06-30) | |
| 16 Jan 2024 | Annual Report and Accounts (to 2023-06-30) | |
| 30 Dec 2022 | Annual Report and Accounts (to 2022-06-30) |
Renalytix is a company that uses artificial intelligence to develop diagnostic tools for kidney disease. Their goal is to improve patient outcomes and reduce healthcare costs by optimizing clinical management of this condition.